1Life Healthcare (ONEM)

Overall impact
B (61)

Commentary

1Life Healthcare is a strong overall performer. With a 'B' rating of 60.6 for overall impact (64th percentile compared to all companies), 1Life Healthcare ranks 402nd out of 585 industry peers, behind Biogen, Ionis Pharmaceuticals, Gilead Sciences and 398 others, and ahead of Grifols, Jazz Pharmaceuticals, Bluebird Bio and 180 others. On top material causes for 1Life Healthcare's industry (Pharmaceuticals & Biotech), 1Life Healthcare performs well in Disease Eradication (96.4 score) and performs poorly in Decent, Safe Work Opportunities (34.5 score) and Reduced Use of tobacco (38.3).
Impact
Cause ONEM
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
3,698
Sector
Health Care
Industry
Biotechnology
Sub-industry
Biotechnology
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
Ca, United States
Share classes
ONEM
Description
1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance plans. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. 1Life Healthcare, Inc. was incorporated in 2002 and is headquartered in San Francisco, California. As of February 22, 2023, 1Life Healthcare, Inc. operates as a subsidiary of Amazon.com, Inc..
Material causes
Ethos considers the following causes material for 1Life Healthcare, based on its industry sub-industry Biotechnology. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.